ENLON 10MG/ML DIN 02188848
Health Canada record
| Active ingredient(s) | EDROPHONIUM CHLORIDE 10 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | V04CX OTHER DIAGNOSTIC AGENTS |
| Original market date | 18-Sep-1996 |
| Current status date | 28-Jan-2008 |
| Source | Health Canada DPD |
Establishment licence of the holder
Baxter Corporation — licence 100278, currently licensed, last inspection rating C (2026-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EDROPHONIUM CHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02056658 | ENLON LIQ IV 10MG/ML | OHMEDA PHARMACEUTICAL PRODUCTS, DIVISION OF BOC CANADA LIMITED | Liquid | EDROPHONIUM CHLORIDE 10 MG | Cancelled Post Market |
| 00855804 | TENSILON | VALEANT CANADA LP / VALEANT CANADA S.E.C. | Liquid | EDROPHONIUM CHLORIDE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 5008 | 1995-10-31 | New Drug Submission (NDS) |
International API supply for EDROPHONIUM CHLORIDE
1 active FDA Drug Master Files.
Request a quote for ENLON 10MG/ML